Handtevy is Revolutionizing Pediatric EMS Care: The Power of Precision in Medication Dosing

Handtevy is Revolutionizing Pediatric EMS Care: The Power of Precision in Medication Dosing

In the fast-paced world of EMS, precision in pediatric medication dosing can mean the difference between life and death. The Monroe-Livingston Regional EMS (MLREMS), led by their Medical Director, Dr. Maia Dorsett, has spearheaded a transformative approach that ensures the safest and most effective treatment for our youngest patients during emergency situations.

Key Insights from the 2024 Pediatric Medication Safety Report:

  • MLREMS introduced the Handtevy system to help accurately dose medications for children, reducing calculation errors common in hectic prehospital settings.
  • Prior to Handtevy, only 70% of pediatric medications were correctly dosed. Post-implementation, this increased significantly, showcasing the app’s impact.

Study Results Highlight:

  • Midazolam for Seizure: Error-free dosing in the last quarter of 2023!
  • Fentanyl for Pain: Marked decrease in dosing variability, although underdosing still occurs.
  • IM Epinephrine for Anaphylaxis: Correct dosing is common, with improved times to administration.

 Survey Insights Post-Handtevy:

  • 96% of ALS clinicians use Handtevy Mobile.
  • Increased comfort and reliance on technology for dosing, though traditional methods like asking parents for weight still dominate.


  • Implementing the Handtevy system significantly improves the accuracy and timeliness of pediatric medication administration in emergency situations.
  • Continuous training and adaptation of new tools are essential to enhance EMS response quality and safety.


Let’s continue to advance our practice for our smallest patients!
Read the Full Case Study Here



Ready to Try Handtevy Mobile?
Schedule a Demo





Peter Antevy, MD



Pediatric Emergency Standards Inc. does not make clinical or medical decisions.  The Handtevy System is intended to be utilized as a guide only.  Provider’s experience and training should be the final determinant of clinical treatment decisions.